Best of SABCS® - South

Regional Director
Kevin Kalinsky, MD and Jane Meisel, MD
Program Goals & Content Overview
As new clinical data continues to emerge as a result of ongoing research in breast cancer diagnostics and therapeutics, official Best of SABCS® programs cover these important developments in each of the live, regional events. Each regional event provides an educational forum for local researchers and clinicians to discuss the most pertinent basic, translational, and clinical breast cancer research presented at the annual SABCS® meeting.
Topics and discussions for each Best of SABCS® program are drawn from key presentations at SABCS® 2023, focusing on results of breast cancer research that helps clinicians understand current trends and forthcoming treatments that will optimize patient care outcomes. Significantly important content from SABCS® includes new drug therapy approvals and clinical trial results, updates in breast cancer screening and diagnostics, and best practices to be implemented in clinical care of patients.
The goals of the Best of SABCS® programs are to review and critically assess practice-changing results of emerging breast cancer research, propose best practices for implementing diagnostic and therapeutic strategies, and close knowledge and clinical practice gaps in the management of patients with breast cancer.
Date & Time
February 10, 2024 8:30 am - 1:30 pm
Location
Auditorium at Emory University Campus, Health Sciences Research Building (HSRB), 1760 Haygood Drive, NE, Atlanta, GA 30322.
Free valet parking will be available on-site.
Program Fee
Physician
$50
Nurse/Nurse Practitioner/Physician Assistant
$25
Resident/Fellow
$25
GASCO Member
$35
Industry
$125

We are pleased to be partnering with the Georgia Society of Clinical Oncology.

A special discounted registration rate of $35 is offered to GASCO professional members

2023 Preliminary Agenda
7:30 - 8:30 AM

Registration Open, Exhibits Open, Continental Breakfast

8:30 - 8:40 AM
Welcome and Program Overview

Kevin Kalinsky, MD, MS - Louisa and Rand Glenn Family Chair in Breast Cancer Research, Professor, Dept.of Hematology and Medical Oncology, Emory University School of Medicine and Director, Glenn Family Breast Center and Winship Cancer Institute. Jane Meisel, MD – Associate Professor, Dept. of Hematology and Medical Oncology and Associate Professor, Dept. of Gynecology and Obstetrics, Emory University School of Medicine. Virginia Kaklamani, MD - Co-Director, San Antonio Breast Cancer Symposium, Professor of Medicine, Mays Cancer Center University of Texas Health Science Center at San Antonio.

8:40 - 9:10 AM
Translational and Biomarker Analysis

Sunil S. Badve, MD, FRCPath, Professor and Vice Chair, Pathology Cancer Programs, Department of Pathology and Laboratory Medicine, Emory University School of Medicine

9:10 - 9:40 AM
HR+ Breast Cancer: Novel Therapeutics in Advanced Breast Cancer

Lisa Carey, MD, ScM, FASCO (INVITED) L. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research; Deputy Director of Clinical Sciences, Lineberger Comprehensive Cancer Center UNC-Chapel Hill

9:40 - 10:10 AM
Survivorship and Health Disparities

Demetria Joy Smith-Graziani, MD, MPH- Assistant Professor, Department of Hematology and Oncology, Winship Cancer Institute of Emory University

10:10 - 10:30 AM
Panel Discussion and Audience Questions and Answers

Moderator - Kevin Kalinsky, MD

10:30 - 10:45 AM

Break and visit with Exhibitors

10:45 -11:15 AM
HR+ Breast Cancer: Treatment of Early Stage Breast Cancer

Virginia Kaklamani, MD, DSc, Co-Director, San Antonio Breast Cancer Symposium, Professor of Medicine, Mays Cancer Center University of Texas Health Science Center at San Antonio

11:15 -11:45 AM
Updates in TNBC and HER2+ Breast Cancer

Alexandra Thomas, MD, FACP - Professor of Hematology and Oncology, Duke Cancer Center

11:45 -12:15 PM
Updates in local-regional Disease

Mylin Torres, MD - Professor, Department of Radiation Oncology Emory University School of Medicine and Co-Leader, Cancer Prevention and Control Research Program, Winship Cancer Institute of Emory University

12:15 -12:40 PM
Panel Discussion and Audience Q and A

Moderator - Jane Meisel, MD

12:40 - 12:50 PM
Review of presentations and post-test

1:00 PM
Adjourn

Accreditation Statement

The UT Health Science Center San Antonio is accredited by the ACCME (Accreditation Council for Continuing Medical Education) to provide continuing medical education for physicians.

The UT Health Science Center San Antonio has approved this program for AMA PRA Category 1 Credits™.

Target Audience
These regional Best of SABCS programs are directed to academic and community physicians, medical residents and fellows training in oncology subspecialties, physician assistants, nurse practitioners and basic/translational researchers involved in breast cancer. Specialties include medical, surgical, gynecologic, and radiation oncology, as well as other pertinent healthcare professionals involved in breast cancer medicine.
These programs are supported by educational grants from
Astra Zeneca
Daiichi Sankyo
Gilead
Hologic
Merck
Novartis
Pfizer
SeaGen
Puma Biotechnology